ENDO 2021 Plenaries

February 04, 2021

Our outstanding slate of world-renowned plenary speakers will showcase the most cutting-edge advances on research and medicine, with presentations spanning the spectrum of science, clinical care, and social implications. Sessions include: 

Presidential Plenary: Big Data and the Future of Endocrine Research

  • Precisely Practicing Medicine from 700 Trillion Points of Data
    Atul J. Butte, MD, PhD—University of California, San Francisco, San Francisco, CA, USA
  • Diabetes Research in the Era of Big Data: The NIDDK Perspective
    Griffin P. Rodgers, MD—National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA

Presidential Plenary: The Impact of Basic Tissue Engineering and the Basic Biology of GPCRs in Emerging Therapies

  • Synthetic Hydrogels as Engineered Niches in Regenerative Medicine
    Andrés J. Garcia, PhD—Georgia Institute of Technology, Atlanta, Georgia, USA
  • Structural Insights Into G Protein Coupled Receptor Activation: Implications for Drug Discovery
    Brian K. Kobilka, MD—Stanford University, Stanford, CA, USA

Bridging the Translational Divide: Successes in Bench to Bedside

  • The Incretin Revolution: Lizard Secrets and Peptide Innovation Change the Management of Diabetes
    Daniel J. Drucker, MD, Lunenfeld-Tanenbaum Research Institute, University of Toronto Mt. Sinai Hospital, Toronto, Canada
  • Genetic Protection from Lipid Accumulation: A Journey from Plaque to Pate
    Helen H. Hobbs, MD, University of Texas Southwestern Medical Center, Dallas, TX, USA

A Deep Dive Into Development and Cancer

  • Cytoskeletal Methylation: A New Cancer Target for the Epigenetic Machinery Outside the Nucleus
    Cheryl L. Walker, Baylor College of Medicine, Houston, TX, USA
  • Understanding Spermatogonial Stem Cells and Male Puberty at the Single-Cell and Genomic Level
    Bradley R. Cairns, PhD, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA

Treating Type 2 Diabetes: New Approaches for an Old Foe

  • A Hepato-Centric View of Diabetes Therapy
    Adrian V. Vella, MD, FRCP, Mayo Clinic, Rochester, MN, USA
  • Hormonal Hybrids for Diabetes and Obesity
    Matthias H. Tschöp, MD, Helmholtz Zentrum Munchen, Germany

What Does Your Gut Tell You? How the Microbiome Modulates Metabolism

  • Multi-Omics Approaches Define New Regulatory Nodes in Cardiometabolic Disease Pathogenesis
    Christopher B. Newgard, PhD, Duke University, Durham, NC, USA
  • The Gut Microbiome: Connections Between Nutrient Sensing, Glucose, and Disease
    Tony K. T. Lam, PhD, Toronto General Hospital and University of Toronto, Canada
Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.